Fundraising Fox

PM Equity Partner

Corporate VC

Lausanne · Series A–Growth · 9 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

PM Equity Partner pursues investments aligned with parent company PMI's strategic priorities. It targets innovative technologies supporting PMI's smoke-free product ambitions, including reduced-risk and oral nicotine products. It has established a wellness investment corridor to access the consumer health market, exploring scientifically substantiated botanical and cannabinoid (CBD) products. It also makes impact investments in sustainable technologies and solutions applicable across PMI's value chain to improve efficiency, reduce costs, save resources, and lower the carbon footprint, aiming to generate strategic value and long-term value creation.

Source: firm website, verified Aug 3, 2026.

Stage
Series A–Growth
Check
$2M – $50M
HQ
Lausanne, CH
Instruments
Equity
Founded
2015
AUM
$350M

Team · 9 people

from public directories
Anna Cotterell· Senior Investment Manager
David Savioz· Senior Investment Manager
Dean Haworth· Investment Director and Head of PMEP
Bruno Chamielec· Vice President Investment

Frequently asked questions

What stage does PM Equity Partner invest at?
PM Equity Partner invests at the Series A, Series B, Series C, Growth stages.
What is PM Equity Partner's typical check size?
PM Equity Partner typically writes checks of $2M – $50M.
What sectors does PM Equity Partner focus on?
PM Equity Partner focuses on Advanced Manufacturing, Biotech, Cleantech, Consumer, Enterprise Software, Hardware, Healthtech, Impact & Social Good, Medical Devices, Wellness & Fitness.
Where is PM Equity Partner located?
PM Equity Partner is headquartered in Lausanne, CH.

Similar investors

Featured in lists